期刊文献+

辛伐他汀对大鼠局灶性脑缺血的线粒体保护作用

Protective Effect of Simvastatin on Mitochondrial in Rats with Focal Cerebral lschemia
原文传递
导出
摘要 目的:探讨辛伐他汀对局部脑缺血损伤大鼠的保护作用及其线粒体机制。方法:96只大鼠随机分为假手术组、缺血再灌注组和辛伐他汀处理组,每组32只。建立大鼠大脑中动脉闭塞(MCAO)模型,观察大鼠神经功能、梗死体积、脑组织线粒体超微结构的改变;检测线粒体细胞色素c氧化酶(COX)、琥珀酸脱氢酶(SDH)活性,Ca^2+含量,以及血清降钙素基因相关肽(CGRP)含量。结果:与假手术组相比较,缺血再灌注组各项指标均有显著改变;与缺血再灌注组比较,辛伐他汀能明显提高脑缺血大鼠的神经功能评分(P〈0.01),缩小梗死体积(P〈0.01),改善脑组织线粒体结构,并提高脑组织线粒体SDH活性(P〈0.05),提高COX活性(P〈0.01),降低脑组织线粒体Ca^2+的含量(P〈0.01),提高血清CGRP水平(P〈0.05)。结论:辛伐他汀可能通过其抗氧化效应,提高脑组织线粒体SDH、COX活性及血清CGRP水平,减轻钙超载,缩小梗死体积,改善神经功能,从而对大鼠局灶性脑缺血起保护作用。 Objective: To investigate the protective effect of simvastafin on focal cerelxal ischemia in rats and its mitochondrial mechanism. Methods: Ninety-six rats were randomly divided into sham operation, ischemia-reperfusion and simvastatin-treated groups (n = 32 in each group). A model of middle cerebral artery occlusion (MCAO) in rats was established using the intraluminal thread method. The neurological function, the size of infarction and the changes of mitochondrial ultrastructure in brain tissues were evaluated. The activities of mitochondrial cytochrorne c oxidase (COX) and succinate dehydmgenase (SDH), the concentration of Ca^2+ and serum calcitma gene-related peptide (CGRP) v, ere measured. Results: All the indexes changed significantly in the ischemia-reperfusion group as compared with the sham operation group. Simvastatin could obviously improve the neurological function scores of focal cerebral ischemia rats (P 〈0. 01), reduce the size of infarction (P 〈 0. 01), improve the mitochondrial structure and increase the activities of SDH (P 〈0.05) and COX (P 〈0. 01), decrease the concentration of mitochondrial Ca^2+ (P 〈0. 01) in brain tissues, and elevate the levels of serum CGRP (P 〈 0. 05) as compared with the ischemia-reperfusion group. Conclusions: Simvastatin may irnprove the activities of SDH, COX and the levels of serum CGRP, reduce Ca^2+ overload and the size of infarction, and irnprove neurological function through its antioxidation effect, and thus play a protective effect on focal cerebral ischemia in rats.
出处 《国际脑血管病杂志》 2007年第5期372-375,共4页 International Journal of Cerebrovascular Diseases
关键词 辛伐他汀 脑缺血 线粒体 神经保护 大鼠 simvastatin cerebral ischemia mitochondfion neuroprotection middle cerebral artery occlusion rat
  • 相关文献

参考文献17

  • 1Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood, 1987, 70:307 -315.
  • 2Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab, 2001,21 : 2 - 14.
  • 3李珺,吴家幂,储照虎,沈衡升.他汀类药物神经保护作用的研究进展[J].国际脑血管病杂志,2006,14(9):696-699. 被引量:20
  • 4Gil-Nunez AC, Villanueva JA. Advantages of lipid-lowering therapy in cerebral ischemia: role of HMG-CoA reductase inhibitors. Cerebrovasc Dis, 2001, 11:85 -95.
  • 5Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke, 1989, 20:84 - 91.
  • 6Garcia JH, Wagner S, Liu KF, et al. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke, 1995, 26:627 -634.
  • 7Bederson JB, Pitts LH, Germano SM, et al. Evaluation of 2,3,5- triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke, 1986, 17:1304 - 1308.
  • 8Costantini P, Petronilli V, Colonna R, et al. On the effects of paraquat on isolated mitochondria. Evidence that paraquat causes opening of the cyclosporin A-sensitive permeability transition pore synergistically with nitric oxide. Toxicology, 1995, 99:77 -88.
  • 9臧莹安,丁发源,向瑞平,唐兆新,王小龙.从动物组织中提取线粒体的方法[J].中国兽医杂志,2006,42(2):61-62. 被引量:5
  • 10程虹.急性脑梗死的溶栓及神经保护剂治疗研究进展[J].国外医学(脑血管疾病分册),1998,6(4):205-208. 被引量:32

二级参考文献74

  • 1陈群,曾因明.Anisodamine protects against neuronal death following cerebral ischemia in gerbils[J].Chinese Medical Journal,2000(7):60-63. 被引量:10
  • 2Taylor TN,Davis PH,Torner JC,et al.Lifetime cost of stroke in the United States.Stroke 1996;27(9):1459-66.
  • 3Endres M,Laufs U,Huang Z,et al.Stroke prevention by HMG-CoA reductase inhibitors mediated by endothelial nitric oxide synthase.Proc Natl Acad Sci USA 1998 ;95(15):8880-5.
  • 4Gil-N AC,Villanueva JA.Advantages of lipid-lowering therapy in cerebral ischemia:role of l HMG-CoA reductase inhibitors.Cerebrovasc Dis 2001;11(SI):85-95.
  • 5Longa EZ,Weinstein PR,Carlson S,et al.Reversible middle cerebral artery occlusion without craniectomy in rats.Stroke 1989;20(1):84-91.
  • 6Garcia JH,Wagner S,Liu KF,et al.Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats.Stroke 1995 ;26(4):627-34.
  • 7Tamura A,Graham DI,McCulloch J,et al.Description of technique and early neuropathological consequences following middle cerebral artery occlusion.J Cereb Blood Flow Metab 1981; 1(1):53-60.
  • 8Bederson JB,Pitts LH,Germano S,et al.Evaluation Of 2,3,5 Triphenyltetrazolium Chloride as a stain for detection and quantification of experimental cerebral infarction in rats.Stroke 1986;7(6):1304-8.
  • 9Costantini P,Petronilli V,Colonna R,et al.On the effects of paraquat on isolated mitocbondria.Evidence that paraquat cause opening of the cyclosporin Asensitive permeability transition pore synergistically with nitric oxide.Toxicology 1995 ;99(1-2):77-88.
  • 10Prass K,Dirnag U.Glutamate Antagonists in therapy of stroke.Neurol Neurosci1998;13(1,2):3-10.

共引文献134

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部